HCPI promotes Methadone Maintenance Treatment in Indonesia's prisons
Last month marked the closure of the Australian Aid funded eight-year HIV Cooperation Program for Indonesia (HCPI), one of the main components of the Australia-Indonesia Partnership for HIV (AIPH). To celebrate HCPI’s legacy of positive impact, we are releasing a series of stories, each exploring key program components and achievements.
Methadone Maintenance Treatment in prisons
Methadone Maintenance Treatment (MMT) played a key role in HCPI’s approach to HIV prevention in Indonesia’s prison system. The use of MMT for incarcerated people who inject drugs (PWID) was first piloted in 2005 in Bali in the Denpasar Prison (commonly known as Kerobokan Prison). This followed an earlier Australian Government-supported study tour for Prison Health officials to observe MMT programs in Australian prisons, and the successful implementation of the WHO MMT pilot in two hospitals in Bali and Jakarta.
The Denpasar Prison MMT pilot produced a range of successes, including a smooth transition from prison to community MMT programs (and vice versa) and early access to HIV treatment, the establishment of comprehensive harm reduction services, ongoing mentoring support, and high levels of MMT participation amongst prisons with opioid dependence. Following on from the success of Denpasar, Indonesia’s Directorate of Corrections (DOC) implemented MMT serviced for PWID in 10 other prisons and detention centers with implementation support from HCPI.
Download the Methadone Maintenance Overview to learn more about HCPI’s work in coordinating methadone maintenance treatment in Indonesia’s prison system.
HCPI has played a key role in the country's response to HIV. The eight year program partnered with the National AIDS Commission, Provincial AIDS Commissions, local health offices and civil society, to support Indonesia in planning, developing and implementing an effective and sustainable response to HIV in all provinces in Java, Bali, and Papua and West Papua. HCPI has also worked to foster leadership within government and civil society to address HIV and AIDS. While the closing of HCPI at the end of June marked the end of the Australian Government’s current long-term investment in strengthening Indonesia’s response to HIV and AIDS through a comprehensive bilateral program, it will maintain support to HIV and AIDS in Indonesia including through its ongoing involvement with the Global Fund and research in HIV treatment.
For more information about HCPI and its legacy of positive impact, please contact Jane Daniels, Palladium APAC Health Practice Director (Jane.Daniels@thepalladiumgroup.com).